Tagged with LEO pharma

Pharma LEO Pharma is expanding its global presence and continuing its leading role in the number of skin disease patients treated and in thrombosis care. Head of the company’s French affiliate, the largest globally, Mr. Guillaume Clement shares his perspective on the company’s new initiatives in efforts to meet ambitious future…

Mexico At Leo Pharma it’s not just about skin conditions. It’s about the people living with them. The recently appointed senior director for Latin America discusses the plans of the company for the region and how, in collaboration with dermatologists, it aims at reaching out to an increasing number of patients.…

Spain Owned completely by the LEO Foundation, LEO Pharma is an extremely patient-centric company focused primarily in the dermatology area. Kristian Hart-Hansen, general manager of LEO Pharma Spain, discusses the challenges in adapting to the country’s regional peculiarities and the subsidiary’s greater commitment to a much more stakeholder-focused approach. What were…

R&D Nuno Brás, General Manager of LEO Farmacêuticos discusses the effect of the crisis on the Portuguese pharmaceutical market, how being a small privately owned company was an advantage during the crisis, and what future growth looks like for the company as well as the industry. You have had the opportunity…

Leo Pharma Ireland This interview also features the comments of Geraldine Murphy, Managing Director of Leo Pharma, Ireland. Ms. Murphy, your transition to your current position was precipitated by a major refocusing that LEO Pharma undertook in the first half of this year. Can you tell us your understanding of the vision behind…

Leo Pharma Ireland This interview also features the comments of Brendan Fitzpatrick, Vice President Finished Goods Manufacturing. Ms. Murphy, your transition to your current position was precipitated by a major refocusing that LEO Pharma undertook in the first half of this year. Can you tell us your understanding of the vision behind the…

Leo Pharma Austria You have been managing LEO Pharma’s Austrian operations since March 2012. How do you look back at these first few months? And what have been your first initiatives at the head of the affiliate? 2012 has overall been an interesting year, as LEO Pharma stepped into new fields of indication…